EastGate Biotech Corp. announced that the company along with its Joint Venture Partner EastGate Biotech Pakistan have agreed to move forward with the development of a new vaccine to combat Coronavirus COVID-19 in China and others affected around the globe. EastGate Biotech Pakistan has access to existing vaccine production companies; some of which already have experience with MERS coronavirus and who are presently conducting clinical studies of the COVID-19 vaccine. Discussions with these manufacturers are well underway. Initially any agreement would involve manufacturing scale of the vaccine to be supplied by the manufacturer. In anticipation of regulatory approval, EastGate Biotech Pakistan is also negotiating commercial manufacturing rights which will enable a smooth transition to larger scale facilities in its Pakistani market. The role of EastGate Biotech would be to potentially register the vaccine for regulatory approval and engage partners in North America.